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Developmentory signaling molecules in many cellular processes. Here we deﬁne differential
functions for ERK1 and ERK2 MAPKs in zebraﬁsh embryogenesis. Morpholino knockdown of ERK1 and ERK2
resulted in cell migration defects during gastrulation, which could be rescued by co-injection of the
corresponding mRNA. Strikingly, Erk2 mRNA cross-rescued ERK1 knockdown, but erk1 mRNA was unable to
compensate for ERK2 knockdown. Cell-tracing experiments revealed a convergence defect for ERK1
morphants without a severe posterior-extension defect, whereas ERK2 morphants showed a more severe
reduction in anterior–posterior extension. These defects were primary changes in gastrulation cell
movements and not caused by altered cell fate speciﬁcation. Saturating knockdown conditions showed
that the absence of FGF-mediated dual-phosphorylated ERK2 from the blastula margin blocked initiation of
epiboly, actin and tubulin cytoskeleton reorganization processes and further arrested embryogenesis,
whereas ERK1 knockdown had only a mild effect on epiboly progression. Together, our data deﬁne distinct
roles for ERK1 and ERK2 in developmental cell migration processes during zebraﬁsh embryogenesis.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe mitogen-activated protein kinase (MAPK) cascade governs key
signaling pathways that control cell proliferation, differentiation and
survival responses in all eukaryotes. Altered MAPK signaling is
associated with developmental defects and various pathologies,
including cancer. The MAPK cascade involves sequential activation of
a serine/threonine kinase (MAPKKK), followedbya dual-speciﬁcMAPK
kinase (MAPKK) and a dual-phosphorylated MAPK target. The
vertebrate family of MAPKs consists of three major subfamilies: ERK,
JNK and p38 (Johnson and Lapadat, 2002). An important challenge is to
understand the complexity of the different MAPK cascades. Although
speciﬁcity of these cascades has been reported (Kolch, 2005), it is clear
that crosstalk occurs and strong indications for redundancies exist
(Johnson et al., 2005). Distinct cellular functions in cancer formation
have recently been shown for ERK1 and ERK2, which are the most
intensively studied MAPKs of the ERK subfamily (Lloyd, 2006). For
example, tumorigenicity of transplanted NIH 3T3 cells stably expres-
sing an oncogenic formof Ras in nudemicewas largely inhibited by co-
transfection of ERK1, but not by ERK2 or p38 (Vantaggiato et al., 2006).(S.F.G. Krens),
lska).
l rights reserved.The canonical pathways of ERK1/2 activation are well studied in
vitro and different animal models have been used to address ERK1 and
ERK2 functions in development. However, due to their crucial roles in
early embryogenesis, the differential functions of ERK1 and ERK2 are
not yet clearly deﬁned. FGF and MEK signaling are necessary for the
formation of notochord and mesenchyme cells during ascidian
embryogenesis (Kim and Nishida, 2001). In Drosophila, FGF-depen-
dent ERK activation was shown to be required for proper mesoderm
dispersal (Gabay et al., 1997; Gryzik and Muller, 2004; Stathopoulos et
al., 2004; Wilson et al., 2005). In chick, functions of activated ERK1/2
in axon growth were suggested (Kato et al., 2005). In Xenopus, ERK2
was shown to be required for mesoderm differentiation (Gotoh et al.,
1995) and neural speciﬁcation (Umbhauer et al., 1995; LaBonne et al.,
1995; Uzgare et al., 1998). Studies using knockout mice clearly
indicated that ERK1 and ERK2 have distinct functions. Gene disruption
of erk2 is lethal during early development, showing that ERK1 is not
redundant to ERK2 (Yao et al., 2003). In contrast, Erk1−/− mice are
viable, fertile and of normal size. However, the proliferation and
maturation of the thymocytes is affected, despite expression of ERK2
(Pagès et al., 1999). Elevated ERK2 activation was observed in primary
neurons isolated from erk1 knockout mice, whereas no higher ERK2
levels were detected in the brain. Mouse embryos lacking exon 2 of the
erk2 gene die in utero before embryonic day (E) 8.5 due to a defect in
trophoblast development. Erk2-deﬁcient mice fail to form the
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al., 2003), and also fail to form mesoderm, based on histological
criteria at E6.5 and E7.5 (Yao et al., 2003). Finally, ERK2 is critical for
proliferation of the trophoblast stem-cell population, which is
essential for placenta formation (Ornitz and Itoh, 2001).
In this study we aimed to increase the understanding of the
differential roles of ERK1 and ERK2 in early vertebrate embryogenesis
and cell migration processes, using the zebraﬁsh model. Because of its
ex utero development the zebraﬁsh model is optimally suitable to
study the link between the cellular and developmental functions of
ERK1 and ERK2. Previously, immuno-histochemical analysis of the
spatio-temporal patterns of ERK1/2 phosphorylation showed that, like
in mouse (Corson et al., 2003) and chick (Delﬁni et al., 2005), zebraﬁsh
ERK1/2 is activated locally during segmentation stages (Shinya et al.,
2001; Sawada et al., 2001). Furthermore, it was shown that insulin-
like growth factors (IGFs) stimulated zebraﬁsh cell proliferation by
activating ERK-MAPK and PI3-kinase signaling pathways (Pozios et al.,
2001). Subsequently, research on the ERK-MAPK pathway in zebraﬁsh
development has mostly concentrated on the functions of the FGF/
MAPK pathway, which also contains the inhibitors Sef (Furthauer et
al., 2002; Tsang et al., 2002) , Sprouty2/4 and the MAPK phosphatases
MKP1 and MKP3 (Tsang et al., 2004). Over-activation of the FGF/ERK-
pathway led to dorsalized embryos by inhibiting expression of bmp
genes (Furthauer et al., 2004). In contrast, over-expression of ERK-
MAPK phosphatase MKP3 or injection of a high dose of mRNA of the
inhibitor Sef resulted in an opposite ventralization (Furthauer et al.,
2002; Tsang et al., 2004).
Recently, we identiﬁed the zebraﬁsh orthologs of the MAPK gene
family and determined their speciﬁc spatial and temporal expression
patterns during zebraﬁsh embryogenesis (Krens et al., 2006). We
showed that the zebraﬁsh genome encodes all members of MAPK-
subfamily, ERK, JNK and p38, and that erk1 and erk2 are differentially
expressed compared to each other and to the other members of the
zebraﬁsh mapk gene family.
Here, we report on knockdown studies of ERK1 versus ERK2 and
present evidence for their differential effects on convergence exten-
sion (CE) cell movements. Cell-tracing experiments showed that ERK1
morphants displayed reduced convergence cell movements, whereas
ERK2 morphants showed a more severe reduction in anterior–
posterior extension of the dorsal body axis, without signiﬁcantly
altering the early cell fate speciﬁcation. Stringent knockdown
conditions for ERK2 arrested embryogenesis at the onset of epiboly,
thereby preventing the blastula to gastrula transition. Taken together,
our data imply distinct functions for ERK1 and ERK2 MAPKs in
gastrulation cell migration during zebraﬁsh embryogenesis. We also
examined the function of FGF signaling at the onset of epiboly by the
use of several inhibitors of the FGF/Ras/MAPK signaling cascade, such
as the chemical FGF receptor inhibitor SU5402, dominant negative
forms of the FGFR1 and 4 and dominant negative hRas (RasN17). In
SU5402-treated embryos, the induction of epiboly was affected in the
same way as in ERK2 morphants and led to the depletion of active
ERK2 signal from the margin. This indicates that FGF-mediated ERK2
activation in the margin plays a key-role in epiboly progression.
Materials and methods
Cloning
Total RNA was isolated from adult Tuebingen zebraﬁsh, using TRIZOL® Reagent
protocol (Invitrogen). cDNA for zebraﬁsh ERK1 and ERK2 genes was cloned into
pCR®4Blunt-TOPO® (Invitrogen) using primers ﬂanking the coding region, based on
EST AB030902 and AB030903, and subcloned in the pCS2+ vector using the EcoR1-site.
Constructs were checked by sequence analysis.
Micro-injection of morpholinos and mRNAs
One-cell stage embryos were injected with 1 nl of the solubilized compounds in 1×
Danieau's buffer [58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mMHEPES; pH 7.6] containing 1% phenol red solution (Sigma). At the 1K-stage (3 hpf),
embryoswith phenol red in the animal polewere selected as positive-injected embryos.
Deﬁnition of stages was according to Kimmel et al. To block translation of the ERK1 or
ERK2 mRNA morpholinos were targeted against the 5′-UTR of the respective mRNAs
(GeneTools Philomath, OR, USA): ERK1MO, 5′-TCTGTCCGCAAATCGTCGCCTTCGC;
ERK2MO, 5′-CACCCAAAAGCACCAGGAAAAGCTC (0.2 mM or 0.4 mM).
Synthetic mRNA encoding zebraﬁsh erk1 and erk2 genes, human RasN17 (Deng and
Karin, 1994), Xenopus XFD (Shinya et al., 2001) or Xenopus bΔFR4 (Hongo et al., 1999)
was transcribed with SP6 RNA polymerase using the mMessage mMachine Kit
(Ambion), using linearized pCS2+ constructs.
Pharmacological inhibition of FGF signaling
To inhibit FGFR activity, embryos were treated with SU5402, (Mohammadi et al.,
1997) (Calbiochem) at 40 μM in deﬁned E2 embryos medium at 28.5 °C in the dark
(Furthauer et al., 2004).
Cell tracing
Embryos were (co-)injected at the one-cell stage with 0.3% 4,5-dimethoxy-2-
nitrobynzyl (DMND)-caged ﬂuorescein dextran (molecular mass 10,000; Molecular
probes, gift from Hammerschmidt lab). Uncaging was performed as previously
described (Bakkers et al., 2004) with UV light at shield stage (6 hpf) using a Zeiss
axioplan microscope, with 40× objective and adjustable pinhole. Embryos were imaged
at 6, 8 and 10.5 hpf. The dorsal convergence and anterior extension angles were
measured using Image J (NIH imaging software).
Whole-mount immuno-staining
Embryos were ﬁxed overnight in 4% paraformaldehyde at 4 °C. Embryos were
washed and incubated for 2 h in blocking buffer (PBS, 0.1% BSAc, 1% Triton X100). After
overnight incubation at 4 °C with 1:100 dilution of primary antibody (Polyclonal
phospho-p44/42 MAPK antibody from Cell Signaling; total ERK antibody K-23, Santa
Cruz Biotechnology) in blocking buffer, embryos were washed with blocking buffer, and
incubation for 1 h in 1:100 diluted secondary antibody (Goat anti-rabbit Alexa 488
conjugated). Embryos were washed in blocking buffer and three washes in PBS
containing 1% Triton X-100.
Whole-mount in situ hybridization
Embryos were ﬁxed overnight in 4% paraformaldehyde in PBS at 4 °C and in situ
hybridization was performed as described previously (Thisse et al., 1993) using the
described probes.
Protein isolation and western blot analysis
Embryos were dechorionated and de-yolked in Ca/Mg free solution. Cells were
pelleted andwashedwith PBS followed by a passive lysis in buffer (0.125% NP40, 25mM
Tris–HCl, 2 mM EDTA, 1 mM Na3VO4, 25 mM NaF and 1 complete mini EDTA-free
protease inhibitor cocktail tablet (Roche) per 10 ml lysis-buffer). Protein extract was
analyzed by western blotting, using phosphor-speciﬁc and total ERK antibody (Snaar-
Jagalska et al., 2003).
Results
Immuno-histochemical analysis of the localization of active/
phosphorylated ERK1 and ERK2 MAPK showed elevated levels of
ERK phosphorylation in the cleavage furrows at the 16 cell stage, in the
margin during epiboly and gastrulation, and at locations of neural
differentiation (anterior neural boundary and mid-hindbrain bound-
ary, Fig. S1) and segmentation (Pozios et al., 2001; Shinya et al., 2001;
Sawada et al., 2001). Immuno-histochemistry cannot distinguish
between ERK1 and ERK2. However, we recently showed that erk1
and erk2 display differential spatio-temporal expression patterns
during zebraﬁsh development (Krens et al., 2006), suggesting distinct
functions for ERK1 and ERK2 during zebraﬁsh development.
Morpholino knockdown of ERK1 and ERK2 results in speciﬁc phenotypes
To elucidate the functions of ERK1 and ERK2 in zebraﬁsh deve-
lopment, gene-speciﬁc morpholinos (MO) directed to the 5′ untrans-
lated sequences, were used to block the translation of erk1 or erk2
mRNAs. Injection of 0.2 mM ERK1MO or ERK2MO induced severe
developmental defects (Fig. 1), while treatment with the same con-
centration of the standard control MO had no effect (data not shown).
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and 85% (n=130) displayed phenotypes characterized by a shorter
body axis and somites without the distinct v-shape (Fig. 1A). In
contrast, ERK2MO injected embryos (n=75) showed approximately
70% lethality at 24 hpf and 85% at 48 hpf (Fig. 1E) and the surviving
ERK2MO morphants showed more severe phenotypes than the ERK1
morphants. At 24 hpf, the head was still distinguishable and the dev-Fig. 1. Speciﬁc ERK1 and ERK2 knockdown by morpholino injection. (A–C) Images show re
compared towild type (wt) embryos (C). (D) Speciﬁc knockdownwas conﬁrmed byWestern
(p42MAPK) protein and detected with global ERK antibody (D). Protein samples were isolate
knockdown and (cross-) rescue experiments determined by co-injection of ERK1 or ERK2
phenotype; white = dead. (F–M) Images show phenotypes of surviving knockdown embryos
1.5pg erk2 RNA) (H, I), embryos injected with mRNA only (J, K) and wild type embryos at 4elopment of tail structures was severely defected (Fig. 1B), resulting in
shortened phenotypes at 48 hpf (Fig. 1G) and somites structures to be
barely recognizable. Approximately 50% of ERK1MO-injected and 15%
ERK2MO-injected embryos survived up to 48 hpf (Fig. 1E). The
surviving morphants were shortened at 24 and 48 hpf and had
enlarged heart-cavities (Figs. 1F, G). Protein analysis of the surviving
embryos by western blot using a general ERK antibody showed thatpresentative examples of the ERK1 (A) or ERK2 (B) knockdown phenotypes at 24 hpf,
blot analysis optimized to discriminate between the sizes of ERK1 (p44MAPK) and ERK2
d from 20 hpf embryos, injected with 0.2 mM ERK1MO or ERK1MO. (E) Statistics of ERK
morpholino with synthetic erk1 or erk2 mRNA at 24 hpf. Black = wild type; gray =
at 48 hpf (F, G), embryos rescued by co-injection of corresponding mRNA (8pg erk1 RNA,
8 hpf (L, M).
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reduced by the respective ERK1 and ERK2 morpholinos (Fig. 1D).
To test the speciﬁcity of the obtained knockdown phenotypes,
rescue experiments were performed using synthetic erk1 and erk2
mRNAs lacking the MO target site. Protein samples were made at the
shield stage from embryos injected with 100 pg mRNA and western
blot analyses showed that the synthetic mRNAs were correctly
translated into proteins and were dual-phosphorylated/activated in
the embryo (Fig. S2B). For rescue experiments mRNA concentrations
were used below those that induced over-expression phenotypes (Fig.
S2). Co-injection of synthetic erk1 mRNA (8 pg/embryo) with 0.2 mM
ERK1MO rescued 67% of embryos with the shorter body axis at 24 hpf
and 50% at 48 hpf (Figs. 1E, H). Co-injection of erk2 mRNA (1.5 pg/
embryo) with 0.2 mM ERK2MO increased the percentage of survivors
from ~20% to more than 70% at 24 hpf and rescued the body axis
defect in ~35% of the embryos (Figs. 2E, I). The redundancy of the ERK1
and ERK2 was determined in cross-rescue experiments using the
same mRNA concentrations as described above (Fig. 2E and data not
shown). ERK1 knockdowns were rescued by co-injection of erk2Fig. 2. Phenotypic characterization of ERK1 and ERK2 morphants in late-gastrulation and ear
control embryos, (B, E, H, K); ERK1 knockdown embryos, injectedwith 0.2 mM ERK1MO, (C, F
yolk plug closure (YPC) to tailbud (TB) stages, animal pole is up, dorsal to right inwild type, E
the length of the AP body axis (Zeiss EC Plan-Neoﬂuar 10×/0.30 objective), or dorsal view (D
40×/0.75 ∞/0.17 objective). (G–L); Combined in situ hybridization on 10-hpf old embryos with
(anterior view, dorsal to top).mRNA with similar efﬁciency as by erk1 mRNA. Co-injection of
ERK2MO with erk1 mRNA did not increase the number of surviving
embryos nor rescued the body axis defects, indicating that the amount
of erk1 mRNA that rescued ERK1 knockdown cannot cross-rescue the
ERK2 knockdown phenotype.
Distinct functions for ERK1 and ERK2 in gastrulation cell movements
The low surviving rates and the severe phenotypes of ERK1 and
ERK2 morphants at 24 hpf indicate possible roles for these kinases in
earlier developmental processes. To address this, ERK1MO and
ERK2MO injected embryos were closely monitored at yolk plug
closure (YPC) to tailbud stages (Figs. 2A–F). ERK1MO-injected
embryos showed rather normal extension (distance between arrow-
heads) compared to control embryos (Figs. 2A, B), but showed a
widening of the notochord (Figs. 2D, E). Strikingly, ERK2MO-injected
embryos showed a shortened anterior–posterior axis at the end of
gastrulation (Fig. 2C), but a far less severe effect on thewidening of the
notochord (Fig. 2F), than ERK1MO-injected embryos.ly segmentation indicates affected cell migration in CE movements. (A, D, G, J); wild type
, I, L); ERK2 knockdown embryos, injectedwith 0.2 mM ERK2MO. (A–C); Live embryos at
RK1MO or ERK1MO injected embryos, The distance between the arrowheads resembles
–F), white spacer highlights the widening of the dorsal notochord (Zeiss Plan-Neoﬂuar
dlx3 (edge neural plate) with shh (midline) or with hgg1 (hatching gland) marker genes
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down on dorsal–ventral patterning or CE cell movements. We ﬁrst
addressed this question by in situ hybridization using the marker
genes dlx3, expressed in the neural plate, sonic hedgehog (shh),
expressed in the notochord, and hgg1, expressed in the developing
hatching gland, in 10 hpf embryos (Figs. 2G–L) as previously described
(Jopling and den Hertog, 2005). In ERK1 morphants, the dlx3-
expression domain was much wider and the hatching gland was
located more posterior (Figs. 2H, K). Strikingly, ERK2 morphants did
not show this widening of the neural plate (dlx3), suggesting that this
defect was ERK1MO speciﬁc. In ERK2 morphants (Figs. 2I, L), the shh
expression domain in the midline was not fully extended in the ante-
rior direction, resulting in a gap between the dlx3 and shh expressionFig. 3. ERK1 and ERK2 are differentially involved in CE cell movements. Embryos were injec
laterally to determine dorsal migration (A–I; animal pole view, dorsal to top) and dorsally to
cells directly after activation (A, D, G, J, M, P), at 8 hpf (B, E, H, K, N, Q) and at 10 hpf (C, F, I, L, O
injected (D–F, M–O) and wild type embryos (G–I, P–R). (S) Quantiﬁcation of dorsal migrati
Quantiﬁcation of anterior migrationmeasured as indicatedwith white arrows (J–R) as degree
type: black diamond.domains. In addition, the expression domain of hgg1was located even
more posterior than in ERK1morphants, indicating affected extension
cell movements in ERK2 morphants.
Knockdown of ERK1 or ERK2 perturbs gastrulation cell movements
differently
In order to directly study the speciﬁc effect of ERK1 and ERK2
knockdown on cell movements during gastrulation, we performed
cell-tracing experiments using DMNB-caged ﬂuorescent dextran
(Kozlowski et al., 1997; Sepich et al., 2000). To follow convergence
(dorsal) cell migration, lateral mesoderm cells located 90° from the
dorsal shield, were labeled by uncaging the ﬂuorophore with a local-ted with MO and caged ﬂuorescein dextran, which was activated at shield stage (6 hpf)
determine anterior extension (J–R; lateral view, dorsal to right). Images show uncaging
, R). Cell-tracing experiments were performed in ERK1MO injected (A–C, J–L), ERK2MO
on (n=10), measured as indicated with white arrows (A–I) as degrees from dorsal. (T)
s of anterior movement (n=10). ERK1MO: gray triangle, ERK2MO: dark gray square, wild
375S.F.G. Krens et al. / Developmental Biology 319 (2008) 370–383ized pulse of ultraviolet light at 6 hpf and followed in time (Figs. 3A–I,
S). Extension cell migration processes were monitored by labeling
cells in the dorsal shield (Figs. 3J–R, T).
The cell-tracing experiments showed that ERK1 morphants dis-
played a severely reduced movement of the labeled lateral cells
towards the dorsal axis in time (Figs. 3A–C), while in ERK2 mor-
phants only a slight reduction of dorsal migration was observed
(Figs. 3D–F). In contrast, ERK2 morphants showed greatly reduced
extension movements (Figs. 3M–O) compared to extension move-
ments in wild type (Figs. 3P–R) and ERK1MO-injcted embryos (Figs.
3J–L). Quantiﬁcation of 10 embryos indicated that the reduction of
dorsal migration for ERK1 knockdown (Fig. 3S) and the reduced
anterior extension migration for ERK2 knockdown (Fig. 3T), were
signiﬁcant, and conﬁrms the previous suggestions based on the in
situ results (Fig. 2). To address if the observed phenotypes in ERK1
and ERK2 knockdown embryos were primary cell movement defects
or secondary effects due to a patterning alteration we performed in
situ hybridization experiments with several different marker genes
and observed no patterning defects (Fig. S3). Together, these results
indicate differentially affected CE movements by ERK1 and ERK2
knockdown.
ERK1 depletion mildly affects epiboly progression, whereas ERK2
depletion causes a developmental arrest at the onset of epiboly
Taken into account that the knockdown of ERK1 and ERK2 was not
completely saturated (Fig. 1D), we applied more stringent knockdown
conditions by doubling the MO concentration and studied the effects
on epiboly (Figs. 4 and S4). Embryos injected with 0.2 mM ERK1MO
(Figs. S4A, B) did not show any obvious phenotype until 80% epiboly,
while doubling the concentration to 0.4 mM slightly delayed epiboly
compared to wild type embryos (Fig. S4G). Embryos injected with
0.2 mM ERK2MO were delayed to 65% epiboly at 8 hpf (Figs. 4 and
S4C), when wild type embryos reached 80%. Knockdown of ERK2 by
injection of 0.4 mM ERK2MO prevented epiboly in 38% (Fig. 4— arrest
category and Fig. S4D) of the injected embryos and inhibited epiboly
progression and further entrance into gastrulation stages in 46% of the
embryos (Fig. 4 severe). This effect was rescued by co-injection of
20 pg synthetic erk2mRNA (Fig. S4E), which resulted in 82% (49 from
60 embryos) of the co-injected embryos entering gastrulation.
Injection of this amount of synthetic erk2 mRNA did not induce any
phenotype by itself, at this stage.
To further address the functional redundancy between ERK1 and
ERK2, we knocked down both genes at the same time by co-
injection of 0.2 mM ERK1MO and 0.2 mM ERK2MO. Double
morphant embryos also showed defects in epiboly. However the
penetrance of the epiboly phenotype was lower than for the singleFig. 4. Classiﬁcation of phenotypes of embryos injected with 0.2 mM or 0.4 mM ERK2MO, com
and arrested phenotype categories is indicated by percentages.0.4 mM ERK2 morphants (65%, n=132 versus 82%, n=103) and in
situ hybridization with ntl revealed that double morphant embryos
still formed some axial mesoderm (data not shown). Considering
that analysis of double morphant embryos does not clarify distinct
roles, but more the global functions of ERK1/2 signaling, we did not
follow up on the double morphant analysis.
To analyze the active ERK signal at early epiboly, phospho-ERK
immune-localization was analyzed by pixel-intensity and section-
ing (Fig. 5), revealing that in addition to the strong phospho-ERK
signal in the margin, active ERK is also present in the rest of the
animal pole (gray-value plot in Fig. 5A). The strongest signal was
detected at the putative dorsal side of the margin at this stage
(Fig. 5B). Sectioning of embryos stained for active ERK1/2 at
oblong, sphere, dome, 30%-, 40%- and 50% epiboly demonstrates
phospho-ERK presence in the EVL from oblong–sphere stage
onwards (Figs. 5C–H). Phospho-ERK was detected in deep cells in
the margin from dome stage onwards (Figs. 5E–H, with magniﬁca-
tion in E′ and H′).
Nomarski microscopy was performed to study the affected epiboly
initiation at 4.5 hpf (Figs. 6A–F). The leading edge of the migrating
cells in the margin and the EVL cells in wild type embryos (Figs. 6A, D)
and ERK1MO embryos (Figs. 6B, E) showed a sharp front migrating
over the yolk. Knockdown of ERK2 induced a discontinuity in the
margin and delayed crowding of the yolk syncytial nuclei (YSN) in the
external yolk syncytial layer (YSL), resulting into a broadened YSL
(Figs. 6C, F).
We performed immuno-histochemistry against the dual-phos-
phorylated ERK1/2 at 4.5 hpf and 8 hpf (Figs. 6G–I,J–L). In the control
embryos (Figs. 6G, J) and the ERK1MO injected embryos (Figs. 6H, K)
phosphorylated ERK was still detected in the margin in both stages.
However, ERK phosphorylation was completely abolished in ERK2MO
injected embryos (Figs. 6I, L) at both stages, indicating that ERK2 is the
active ERK MAPK in the margin during gastrulation cell movements
and that ERK2 plays a key-role in epiboly progression.
As previously described in studies using Xenopus and mice,
ERK2 is required for mesoderm differentiation (Gotoh et al., 1995;
Yao et al., 2003). Therefore the expression of the mesoderm
markers ntl (brachyury in Xenopus) and tbx6 in both ERK1 and
ERK2 morphants was tested (Figs. 6M–R). In ERK1 morphants we
observed a slight reduction of ntl and tbx6 expression in the
margin, where ntl expression stayed strongly expressed at the
putative dorsal side, and tbx6 expression was diminished at this site
(Figs. 6N, Q). In ERK2 morphant, ntl and tbx6 expression was almost
absent (Figs. 6O, R), showing impaired mesoderm differentiation
(Yao et al., 2003).
Experimental evidence in Fundulus demonstrated that the YSL is
still able to epibolize when the overlying blastoderm and EVL arepared to wild type embryos at 8–9 hpf. Classiﬁcation into wild type, light, mild, severe
Fig. 5. Active ERK is localized in the EVL prior epiboly and detected in EVL and marginal deep cells upon epiboly initiation. Embryos were ﬁxed and subsequently stained for ERK
activation by immuno-ﬂuorescence at 30% epiboly (A, lateral view, dorsal to right and panel B, top view, dorsal to top) and quantiﬁed by pixel-intensity plots (gray-value in graphs). The
phospho-ERK signal was weakly detected in the whole animal pole and stronger in the margin, with the strongest signal in the putative dorsal margin (B). Sectioning of embryos AP-
stained for active ERK1/2 at epiboly initiation: oblong, sphere, dome, 30%-, 40%- and 50% epiboly (C–H respectively; lateral view of 8 μm section, images with Zeiss EC Plan-Neoﬂuar 10×/
0.30 objective, presumptive dorsal to right), revealed that phospho-ERK is present in the EVL from oblong–sphere stage onwards (C–H). Phospho-ERK was detected in deep cells in the
margin from dome stage onwards (E–H, with magniﬁcation in panel E′ and H′). Arrowheads indicate initial detection of the signal (EVL in panel D, ventral and dorsal margin in panel F).
376 S.F.G. Krens et al. / Developmental Biology 319 (2008) 370–383removed. This indicates that YSL epiboly can still occur in embryos
lacking mesoderm (Betchaku and Trinkaus, 1978). The migration of
the YSN to the vegetal pole is considered as a driving force through all
stages of epiboly (Kane et al., 1996), next to radial intercalation (Myers
et al., 2002; Montero and Heisenberg, 2004; Solnica-Krezel, 2006). At
late blastula stages, the YSL forms a broad band and contains most of
the YSN. At sphere/dome stage, the wide belt of external YSL narrows
in the animal-vegetal direction and the YSN become increasingly
crowded. When the blastoderm expands vegetally, reaching 30%
epiboly, the YSN of the external YSL concentrate near the EVL at the
margin (Solnica-Krezel and Driever, 1994). To follow migration of the
YSN in vivo, 10 μM SYTOX-green nucleic acid stain was (co-)injected in
wild type control embryos and morpholino-treated embryos (Figs.
7A–F). At 8 hpf, the YSN of control embryos were at 80% epiboly (Fig.
7D), whereas the YSN of ERK1morphants were delayed at 50% epiboly
(Fig. 7E). In ERK2 morphants the YSN were located at the top of the
yolk at 8 hpf and did not show any migration towards the vegetal pole
(Fig. 7F), leading to the conclusion that the depletion of activated ERK2
from the margin prevents YSL-migrating to the vegetal pole.
To initiate crowding of the YSN at sphere/dome stage, the
microtubule network of the external YSL contracts and becomes
denser at the margin (Solnica-Krezel and Driever, 1994). Theimmuno-histochemistry of tubulin (Figs. 7G–L) revealed a narrow
band of microtubules in the YSL in wild type embryos (Fig. 7G,
enlarged in Fig. 7J) and ERK1MO injected embryos (Figs. 7H, K). In
ERK2MO injected embryos (Figs. 7I, L) narrowing of the micro-
tubules of the YSL did not occur, revealed by the broader YSL in the
ERK2 depleted embryos.
The actin cytoskeleton within the YSL and EVL also fulﬁlls an
important role during epiboly as it has been shown that the disruption
of the actin-based structures leads to the slowing or immediate arrest
of epiboly (Cheng et al., 2004). In a study by Köppen et al., it was
indicated that cell shape at the epithelial margin is of critical
importance. The movement of the outer epithelium (EVL) over the
yolk cell surface involves the contraction of the marginal cells. This
process depends on the recruitment of actin and myosin2 within the
yolk cytoplasm along the margin of the enveloping layer (Köppen et
al., 2006).
To address whether the cell shape and the recruitment of actin to
the blastula margin was affected, we stained the embryos with
Alexa568-labeled phalloidin (Figs. 7M–R). Enriched phalloidin-stain-
ing was observed within the YSL along the EVL margin in wild type
(Figs. 7M, P) and ERK1MO injected embryos (Figs. 7N, Q). In ERK2
morphants this enrichment was clearly weaker (Figs. 7O, R).
Fig. 6. Saturating knockdown of ERK2 prohibits epiboly initiation and revealed ERK2 to be the active MAPK in the margin. Embryos were injected with 0.4 mM ERK1MO (B, E, H, K, N,
Q) or ERK2MO (C, F, I, L, O, R) and compared to wild type embryos (A, D, G, J, M, P). Nomarski/differential interference contrast (DIC) microscopy using a Zeiss EC Plan-Neoﬂuar 10×/
0.30 objective (A, B, C) and a Zeiss Plan-Neoﬂuar 40×/0.75 ∞/0.17 (D, E, F) was used tomonitor the margin at the onset of gastrulation (4.5 hpf). Localization of dpERK was detected by
immuno-localization in wild type, ERK1MO and ERK2MO injected embryos at 4.5 hpf (G–I) and 8 hpf (J–L) by phospho-speciﬁc ERK antibody. Images in panels G–L were taken by
confocal laser scanning microscopy. Mesoderm formation was followed using in situ hybridization markers ntl (M–O) and tbx6 (P–R), top view, presumptive dorsal side right.
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Fig. 7. Depletion of active ERK2 affects migration of the YSL, cytoskeleton reorganization and cell shape. (A–F) YSL-migration was followed in vivo by co-injection of 10 mM sytox
green at 4.5 hpf (A–C) and 8 hpf (D–F). The animal-to-vegetal migration of the YSNwithin the YSL is indicated with a red arrowhead. The YSL of ERK2 morphants does not migrate to
the vegetal pole in time (C, F) as in wild type embryos (A, D) or ERK1 morphants (B, E; slightly delayed). (G–L) Tubulin cytoskeleton was analyzed by antibody staining (G–I, Zeiss EC
Plan-Neoﬂuar 10×/0.30 objective; J–L, Zeiss Plan-Neoﬂuar 40×/0.75 ∞/0.17). Tubulin structures nicely condensate at the vegetal base of the YSL in wild type embryos (G, J) and ERK1
morphants (H, K), but this is perturbed in ERK2 morphants (I, L). (M–R) Actin cytoskeleton was analyzed by Phalloidin staining (M–O, 10× objective; P–R, 40× objective). Local actin
recruitment in the YSL is observed in both wild type (M,P) and ERK1 morphants (N, Q), but not in ERK2 morphants (O, R). The red asterisks indicate stretched cells, only observed in
wild type and ERK1morphants. (S, T, U); lateral view, dorsal to right. FITC dextran-labeled wild type, ERK1MO or ERK2MO is transplanted intowild type hosts and grown to complete
epiboly. (V); Schematic representation of a double transplantation experiment. Wild type embryos are injectedwith Rhodamin dextran, morphant embryos are co-injectedwith FITC
dextran. Embryos are grown till sphere stage and cells from both donor embryos are transplanted into the anima pole of awildtype acceptor embryo and let to develop. (W, X) Overlay
of images taken by confocal laser scanning microscopy of co-transplanted wild type (red) and ERK1 or ERK2 morphant cells (green) into wild type hosts at approximately 7 hpf, with
enlargements in (S, T). Yellow arrowheads indicate ﬁlopodia formation by wild type cells; white arrowheads indicate ﬁlopodia formation by morphant cells (only in panel S). Dotted
lines in panels W and X indicate epiboly progression and the outline of the embryo.
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stretchedcellswere observed inbothwild typeandERK1morphants (to
a lesser extend), but not in ERK2 morphants (Figs. 7P–R, red asterisk).
To test if the epiboly defect could be due to arrested development
rather than to speciﬁc defects in morphogenesis, we performed
transplantation experiments (Figs. 7S–Z). FITC-labeled morphantcells transplanted to a wild type host were still able to undergo
epiboly, but at tail bud stage ERK2 morphant cells were found not to
have migrated as far to the vegetal pole when compared to ERK1
morphant or wild type transplanted cells (Figs. 7S–U).
Double cell transplantations were performed to determine
their relative positioning and if affected cell shapes as observed in
Fig. 8. Chemical inhibition of FGF signaling phenocopies ERK2MO affects and prevents epiboly initiation. Representative embryos treated with DMSO (A), SU5402 (B) or injected with
ERK2MO (C). Both SU5402 (40 μM) treated and ERK2 depleted embryos do not initiate epiboly, whereas (co-)injections of synthetic mRNA encoding XFD and bΔFR4 (800 or 400 pg
total, ratio 1:1), XFD only (400 pg) or Ras N17 (800 or 400 pg) did not affect epiboly initiation signiﬁcantly (D; percentages indicated below the graph). (D) Injected or SU5402 treated
embryos were analyzed for active ERK signaling (dpERK) after the mentioned treatment, at 4 hpf. The observed dpERK phenotypes were imaged from the top and classiﬁed in 4
groups; staining in the margin like in wild type conditions (wt; black), depletion of dpERK from the margin, but still present at the putative dorsal side (dorsal signal; light gray), no
signal in the margin, but scattered pattern of cells expressing dpERK (scattered; dark gray) and no signal detected (white). The different phenotypes were scored per treatment and
the percentages were plotted in a graph (D).
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ERK2 morphant were co-transplanted with rhodamin-labeled wild
type cells into a wild type host at sphere stage (Fig. 7V) and imaged at
8 hpf (Figs. 7W, X). These studies conﬁrmed that ERK2 morphant cells
were less efﬁcient in epiboly compared towildtype and ERK1morphant
cells migration (Figs. 7W, X). The transplanted wild type cells showed
clear stretching and the formation of ﬁlopodia. These features were
reduced in ERK1 morphant cells (green cells in S) and completely
absent in ERK2 morphant cells (green cells in T), indicating that this
effect was cell autonomous. Together, these data suggest that ERK
morphant cells are affected in their migration properties, but not
completely impaired. The observed ERK2 phenotype probably caused
by combined cell migration and cytoskeleton reorganization defects.
To exclude a proliferation defect due to the depletion of functional
ERK1 or ERK2 protein, phosphorylated histone H3 was used as a
proliferation marker (Fig. S5). The presence of phospho-histone H3
was assayed in wild type and morphants at 30% (Figs. S5A–C) and 80%(Figs. S5D–F) epiboly and embryos were counterstained with
phalloidin to outline the embryos. Phosphorylated histone H3 was
detected in all embryos tested and indicates that proliferationwas still
present in ERK1 (Figs. S5B, E) and ERK2 (Figs. S5C, F) morphants at
both time points. We also performed in situ cell-death staining by
TUNEL (Figs. S5G–K) to determine if apoptosis was induced by either
the knockdown of ERK1 or ERK2. In the ERK2MO arrested embryos
some positively stained cells were found at 8 hpf, however the
apoptosis-related nuclear fragmentation was not observed (data not
shown). Knockdown of ERK1, like in the wild type embryos, did not
show any apoptosis at this stage.
Chemical inhibition of FGF signaling phenocopies the ERK2MO
phenotype and prevents epiboly initiation
To address the possible involvement of FGF signaling as one of the
predominant activators of ERKs during development, we performed
Fig. 9. Model for the distinct role for ERK1 and ERK2 during developmental cell
migrations processes. (A) Represents the distinct effects of ERK1 and ERK2 knockdown
on conversion-extension, as knockdown of ERK1 affected conversion to a greater extent,
while the effect of ERK2 knockdown was more pronounced on extension. (B) Depicts
the crucial role for FGF mediated ERK2 activation in the margin to initiate epiboly.
Depletion of the active ERK2 signal from the margin by complete FGF inhibition or ERK2
knockdown prevents the blastomeres to initiate epiboly and subsequent gastrulation.
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Wild type embryos were dechorionated manually and treated with
40 μM SU5402 (Furthauer et al., 2004) from the 16-cell stage. Control
embryos were treated with the same amount of DMSO solvent. The
DMSO control embryos did not show any obvious phenotypes and
initiated epiboly normally (Fig. 8A, ~100%). SU5402 treated embryos
phenocopied severe ERK2 morphants (Fig. 8C) and did not initiate
epiboly (Fig. 8B, ~85%, n=84 from two independent experiments).
SU5402 treatment with lower concentration (20 μM) did not block
epiboly.
To conﬁrm the role of FGF signaling at the onset of epiboly and
show the speciﬁcity, we also performed co-injections with mRNA
encoding dominant negative FGF receptor 1 (XFD), dominant negative
FGFR4 (bΔFR4) (Shinya et al., 2001) and the dominant negative H-Ras
(RasN17). The injected embryos were scored for epiboly initiation (Fig.
8D), and embryos were subsequently analyzed for active ERK signal,
by immuno-detection (dpERK). The observed dpERK phenotypes were
classiﬁed in 4 groups; staining in the margin (black), depletion of
dpERK from the margin, but still present at the putative dorsal side
(light gray), no signal in the margin, but scattered pattern of cells
expressing dpERK (dark gray) and no signal detected (white). The
percentages of the different dpERK phenotypes (n=30 per condition)
are represented in Fig. 8D. Injection of the various compounds did
lower the levels of dpERK but none of these conditions showed the
same phenotype on active ERK signaling as ERK2MO injection or
SU5402 treatment (Fig. 8). In addition, we were not able to rescue
embryos treated with saturating concentrations of SU5402 by co-
injection of constitutively active forms of RAS (ca-Ras). Injection of ca-
Ras can lead to early proliferation defects even before the epiboly
arrest phenotype can be observed (Furthauer et al., 2002;Tsang et al.,
2002), whereas injection of lower doses of ca-RAS did not rescue the
epiboly arrest.Together, our results provide evidence that mild knockdown of
ERK1 and ERK2 affects CE movements differentially, without sig-
niﬁcantly altering early developmental patterning. ERK1 morphants
showed a reduced convergence defect without a severe anterior–
posterior extension defect, whereas ERK2 morphants did show a
severe anterior–posterior extension defect without a signiﬁcant
convergence defect (Fig. 9A). Further analysis, using stronger knock-
down conditions revealed that ERK2 is the active MAPK in the blastula
margin. This indicates that the absence of this active ERK2 from the
margin at the blastula to gastrula transition blocks the FGF mediated
signaling that leads to initiation of epiboly. This subsequently prevents
further progression of gastrulation cell migration processes, leading to
an arrest in embryogenesis (Fig. 9B).
Discussion
The ERK MAPKs are among the most studied signaling molecules,
however the speciﬁcity of MAPKs in the developmental processes is
not well understood. In this study we show that ERK1 and ERK2 have
distinct roles in epiboly and CE movements during zebraﬁsh
embryogenesis. We present data demonstrating that ERK1 knock-
down affects convergence to a larger extend, while ERK2 knockdown
predominantly affects anterior–posterior extension during gastrula-
tion cell migration processes (Fig. 9A). In addition, complete depletion
of active ERK2 from the blastula margin prohibited proper cytoske-
leton reorganization involved in epiboly initiation and led to an arrest
of embryogenesis (Fig. 9B).
Different lethality of ERK1 versus ERK2 knockdown
Morpholino knockdown of ERK1 and ERK2 resulted in a shorter
body axis and affected somite shape. Knockdown of ERK2 also
disrupted the formation of the MHB and was more lethal than
knockdown of ERK1 (Fig. 1). This is in agreement with gene targeting
results in mice showing that erk1−/− mice are viable and without
embryonic phenotypes, whereas erk2−/− mice are lethal (Pagès et al.,
1999). In zebraﬁsh, the same amount of erk2 mRNA that rescued
morpholino knockdown of ERK2 was also able to cross-rescue knock-
down of ERK1. In contrast, the erk1mRNA could not cross-rescue ERK2
morphants. Our results support the suggestion of Yao et al. that ERK2
can compensate for the loss of ERK1 (Yao et al., 2003; Saba-El-Leil et al.,
2003). In addition, double ERK1 and ERK2 knockdown does not
completely synergize to phenocopy the stronger knockdown conditions
of ERK2, indicating distinct functions for ERK1 and ERK2. The difference
between the observed developmental defects and lethality in zebraﬁsh
ERK1 morphants and the lack of a severe phenotype in erk1−/− mice
(Mazzucchelli et al., 2002) is remarkable and suggests different
redundancy and adaptation mechanisms in these organisms.
Distinct roles for ERK1 and ERK2 in convergence and extension cell
movements during gastrulation
Phenotypes of surviving ERK1 and ERK2 morphants indicated
possible effects in CE cell movements. In situ hybridization using
combinations of markers for these processes supported this hypoth-
esis (Fig. 2), while in situ hybridization experiments with patterning
marker genes did not show a signiﬁcant altering of the early cell fate
speciﬁcation (Fig. S3). Indications for distinct loss-of-function defects
of ERK1 versus ERK2 knockdown on CE cell movements during
gastrulation were directly addressed by cell-tracing experiment in
ERK1 and ERK2 morphants (Fig. 3). We found that CE movements
were differently affected upon ERK1 versus ERK2 knockdown as ERK1
morphants showed a convergence defect without a severe posterior-
extension defect, whereas ERK2 morphants showed a more severe
reduction in anterior–posterior extension, pointing towards different
downstream targets of ERK1 and ERK2 and divergence of ERK
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that ERK1 also is involved in cell migration processes, as they show
that the ERK1 speciﬁc scaffold protein MP1, and its partner p14 are
required for Rho/Rho kinase functions, involved in the turnover of cell
adhesions and cytoskeleton rearrangements important for cell
motility of REF52 ﬁbroblasts (Pullikuth et al., 2005).
CE movements during zebraﬁsh gastrulation involve different
cellular events depending on the position of the cells along the dorso-
ventral axis (Myers et al., 2002). Dorsal convergence appears to
require migration of cells on the extracellular matrix, while extension
movements might be dependent on cell–cell adhesion, involving
neighboring cells crawling over the surfaces of the surrounding cells.
Importantly, studies in zebraﬁsh demonstrated that convergence and
extension cell movements may be considered as separate morphoge-
netic movements of gastrulation cell migration in zebraﬁsh (Glickman
et al., 2003; Bakkers et al., 2004; Daggett et al., 2004). In other model
systems interaction between ERK signaling and cell migration during
gastrulation was also observed (Bottcher and Niehrs, 2005).
Epiboly initiation requires active/phosphorylated ERK2 in the blastula
margin
Saturating knockdown conditions were applied to address the
possible functions of ERK1 and ERK2 in epiboly initiation, since
phosphorylated ERKs were previously detected in the blastula margin
(Fig. S1). The increased knockdown of ERK1 only slightly delayed
epiboly, whereas 84% of the ERK2MO injected embryos did not initiate
epiboly at all. Immuno-histochemical studies on ERK1 and ERK2
morphants using a phospho-ERK antibody showed that ERK2 is
speciﬁcally activated in the blastula margin (Fig. 5) and crucial for
epiboly progression. Our results indicate that depletion of this active
ERK2 from the margin prevents cells from the animal pole to migrate
over the yolk–cell at the onset of epiboly (Fig. 6). In addition,
migration of the YSL to the vegetal polewas prevented (Fig. 7), thereby
removing one of the motors for gastrulation movements (Solnica-
Krezel and Driever, 1994; D'Amico and Cooper, 2001; Solnica-Krezel,
2006).
The impaired epiboly in ERK2 morphant embryos is accompanied
by severe mesoderm induction defects (Fig. 6). To exclude that the
epiboly defect is just due to defected mesoderm development rather
than speciﬁc defects in morphogenesis, we demonstrated that
transplanted cells from severe ERK-morphants into a wild type
background were still able to undergo epiboly with reduced cell
migration efﬁciency. Importantly, it has been described that epiblast
and hypoblast layers can move independently. For instance, in
maternal-zygotic one-eyed pinhead mutant embryos, which lack
hypoblast cells, epiblast cells still epibolize properly (Hammerschmidt
et al., 1996). This indicates that the observed epiboly arrest in ERK2
morphants likely is not due to defected mesoderm formation, but is
caused by defects in cell migration and cytoskeleton reorganization.
FGFs act as activators of ERK2 in the blastula margin
Our results suggest that activation of ERK2 plays a major role in
early epiboly initiation. The question remains which signaling cascade
that regulates the onset of epiboly, is blocked by ERK2 knockdown. At
the upstream signaling level multiple interconnected signaling path-
ways, such as Nodal, Wnt, BMP and FGF, act together to coordinate
epiboly and gastrulation processes (Schier, and T.W.S., 2005) and are
therefore possibly connected with ERK2 activation. In Drosophila, Xe-
nopus, mouse and zebraﬁsh, the functions of ERK MAPKs are often
related to FGF signaling. In the early mouse gastrula, FGFs are required
for the migration of the epiblast cells out of the primitive streak (Sun
et al., 1999). In chicken, FGFs signal as chemotactic cues during
gastrulation, and coordinate cell movements during ingression of the
epiblast cells through the primitive streak (Yang et al., 2002). Duringearly mesoderm migration in Drosophila, the local MAPK activation
pattern suggests that the FGF receptor (Htl) is speciﬁcally activated at
the leading edge of the migrating mesoderm cells (Gabay et al., 1997;
Gryzik and Muller, 2004). In zebraﬁsh development, activated ERK
proteins are localized in overlapping expression regions with various
FGF ligands and other components of the FGF pathway (Fig. S1)
(Pozios et al., 2001; Sawada et al., 2001; Furthauer et al., 2002; Tsang
et al., 2002; Poulain et al., 2006). In previous studies inhibition of the
FGF pathway resulted in tailless phenotypes, similar to ERK1 and ERK2
morphants (Figs. 1 and S6) (Grifﬁn et al., 1995; Draper et al., 2003;
Grifﬁn and Kimelman, 2003; Mathieu et al., 2004). Therefore we
examined the involvement of FGF signaling at the onset of epiboly by
the use of several inhibitors of the FGF/Ras/MAPK signaling cascade.
Saturated inhibition of FGF signaling by SU5402 treatment resulted in
complete phenocopy of ERK2 morphant phenotypes (Fig. 8), demon-
strating for the ﬁrst time an important role for FGF-mediated ERK2
activation at the onset of epiboly. Injection of dominant negative
FGFR1 or dominant negative hRas (N17) only, or co-injection of
dnFGFR1 with dnFGFR4 (bΔFR4) led to diminishing of active ERK2
signal, without affecting epiboly initiation. This suggests more genes
of the FGF family or different signaling processes to be involved. It has
been described that FGFR signaling involves activation of multiple
downstream signaling cascades (Coumoul and Deng, 2003; Bottcher
and Niehrs, 2005; Thisse and Thisse, 2005). For instance, using
different chemical strategies to inhibit phosphatidylinosito-3 kinase
signaling during Xenopus mesoderm inductions, it was shown that
PI3K can act in parallel to ERK signaling in response to FGF (Carballada
et al., 2001). Studies using the ascidian Ciona demonstrate that the
phenotypical outcome of chemical inhibition of FGF signaling depends
on the timing of drug application (Kim and Nishida, 2001). Attempts
by other labs to block FGF signaling by triple knockdown of FGF8,17b
and 24 in zebraﬁsh did not inhibit epiboly initiation (Raible and Brand,
2001; Draper et al., 2003; Furthauer et al., 2004; Tsang et al., 2004;
Poulain et al., 2006), indicating the complexity of this process.
ERK signaling is essential for effective actin accumulation at the EVL and
microtubule reorganization in the YSL during epiboly
In the next course of our study we addressed the question how
ERK2 signaling controls epiboly progression and integrates with
cytoskeleton reorganization at the onset of gastrulation cell move-
ments. The migration of the YSN to the vegetal pole is considered as a
driving force through all stages of epiboly (Kane et al., 1996), next to
radial intercalation (Myers et al., 2002;Montero andHeisenberg, 2004;
Solnica-Krezel, 2006). At late blastula stages, the YSL forms a broad
band and contains most of the yolk syncytial nuclei (YSN). At sphere
stage, the YSN of the YSL crowd into one plain to initiate epiboly. This
process is mediated by the microtubule network of the external YSL,
which contracts and becomes denser at themargin (Solnica-Krezel and
Driever, 1994), thereby aligning the YSN lateral to the blastula margin.
Depletion of ERK2 severely affects this microtubule mediated process
and the YSN do notmigrate to the vegetal pole. In vitro studies showed
that active ERK is involved in microtubule destabilization (Harrison
and Turley, 2001). Therefore the loss of ERK signaling is likely to disturb
microtubule stability in the YSL as we observed in our knockdown
study.
The movement of the EVL over the yolk surface involves the
constriction of marginal cells, a process that depends on the
recruitment of actin andmyosin2 along themargin of the EVL (Köppen
et al., 2006). The recruitment of actin to themarginwas not observed in
ERK2 morphants, suggesting a mechanism why the EVL of ERK2
morphants did not go into epiboly (Fig. 8). A possible mechanistic link
between ERK1/2 signaling and actin reorganizationmight bemediated
by Paxillin. Paxillin is a focal-adhesion adaptor involved in focal-
adhesion dynamics and cell migration (Turner, 2000). The direct
upstream ERK-activator MEK is constitutively associated with Paxillin
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ERK to Paxillin to mediate ERK activation at focal complexes, therefore
Paxillin can serve as an ERK-regulated scaffold for coordinated FAK and
Rac activation in epithelial morphogenesis (Ishibe et al., 2004). In
zebraﬁsh, activated Paxillin, focal-adhesion kinase (FAK), and cadherin
co-distribute at the lateral membranes of the EVL during early
morphogenesis (Crawford et al., 2003). In this study we found
elevated levels of phosphorylated ERK within the EVL and even
stronger signals at the margin to yolk interface, allowing for
speculation that active ERK signaling is involved in focal-adhesion
assembly and disassembly between the EVL and YSL, but its precise
role and the mechanism should be clariﬁed or conﬁrmed by further
studies. Together, we conclude that the absence of microtubule-
dependent migration of the YSN and actin-reorganization defects by
ERK2 knockdown contributes to the developmental arrest at the
blastula to gastrula transition.
A number of mutants described for epiboly arrest show delayed or
arrested epiboly at later stages, but not a block at blastula to gastrula
transition (Kane et al., 1996). For example, different hab alleles,
containing mutations in the cell adhesion molecule E-cadherin
(cdh1), arrest epiboly of deep cells at mid-gastrulation, whereas
epiboly of EVL and YSL proceeds further (Kane et al., 2005; Shimizu et
al., 2005). Reduction of E-cadherin protein levels by morpholino
knockdown also delayed epiboly and affected intercalation and
possibly extension cell migration (Kane et al., 2005). Stronger loss
of E-cadherin function impaired epiboly at earlier stages (Babb and
Marrs, 2004), similar as observed in our study of ERK2 morphants.
The morphological changes characteristic for an EMT-like transition;
cytoskeleton reorganization and disruption of cell junctions are
however, independent of cadherin switching. This indicates that the
developmental defects in the morphants are caused defects on
multiple levels. An interesting link is starting to emerge between
activation of ERK MAPKs via hepatocyte growth factors and the
regulation of E-cadherin expression via snail in cancer processes
(Medici et al., 2006; Grotegut et al., 2006). In future studies we would
like to address the link of ERK MAPK with FGF, E-cadherin and other
signaling components using micro-array analyses in the different ERK
knockdown backgrounds, and address the molecular mechanism of
ERK activation integrates with cytoskeleton reorganization required
for gastrulation cell movements.
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